Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Korenberg Matthew E
President & COO at LIGAND PHARMACEUTICALS. Filing since 17 Nov 2017.
CIK 0001649903
Company
Date
Role
Action
Shares
Amount
Of holding
LGND
LIGAND PHARMACEUTICALS INC
23 Sep 2024
President & COO
Sold at will
9,772
$989.12K
16.1%
LGND
LIGAND PHARMACEUTICALS INC
20 Sep 2024
President & COO
Sold at will
6,275
$653.24K
11.0%
LGND
LIGAND PHARMACEUTICALS INC
26 Aug 2024
President & COO
Sold at will
11,389
$1.20M
18.7%
LGND
LIGAND PHARMACEUTICALS INC
23 Aug 2024
President & COO
Sold at will
6,312
$661.48K
9.4%
LGND
LIGAND PHARMACEUTICALS INC
22 Aug 2024
President & COO
Sold at will
1,157
$122.11K
1.7%
LGND
LIGAND PHARMACEUTICALS INC
9 Aug 2024
President & COO
Sold at will
18,245
$1.80M
21.1%
LGND
LIGAND PHARMACEUTICALS INC
14 May 2024
President & Chief Operating
Sold at will
14,158
$1.20M
14.1%
LGND
LIGAND PHARMACEUTICALS INC
13 May 2024
President & Chief Operating
Sold at will
3,440
$290.83K
3.3%
LGND
LIGAND PHARMACEUTICALS INC
3 Sep 2019
EVP,Finance & Strategy and CFO
Bought
500
$43.09K
3.0%
LGND
LIGAND PHARMACEUTICALS INC
29 Aug 2018
EVP,Finance & Strategy and CFO
Sold, plan not stated
18,357
$4.71M
73.1%
LGND
LIGAND PHARMACEUTICALS INC
17 Nov 2017
VP, Finance and CFO
Sold, plan not stated
6,559
$935.51K
44.6%
11 decisions on file.
